Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Information on shares, voting rights and authorized capital
-
Form 8.3 - Idox Plc
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Form 8.3 - Empiric Student Property Plc
-
Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives
-
SEPA Reappoints Duke Energy, Holy Cross Energy and SMUD Leaders to Board of Directors
-
Silynxcom Announces Over $1.3 Million in Purchase Orders from Israeli Defense Forces and Tactical Units in Recent Months
-
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
-
Silynxcom Announces Over $1.3 Million in Purchase Orders from Israeli Defense Forces and Tactical Units in Recent Months
-
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
-
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment
-
Financial Calendar 2026
-
Form 8.3 - Avadel Pharmaceuticals plc
-
ECD Automotive Design Showcases the Modern Potential of Classic Series Vehicles with Project Inizio
-
Vanguard Announces Final Cash Distributions for the Vanguard ETFs
-
Vanguard Investments Canada Announces Final 2025 Annual Capital Gains Distributions for the Vanguard ETFs® - VBU, VBG and VGAB
-
Join Alliance Entertainment’s Exclusive Live Investor Webinar and Q&A Session on January 5
-
NewtekOne, Inc. to Host Investor/Analyst Day on January 8, 2026
-
NANO Nuclear Energy’s Strategic Laser Uranium Enrichment Partner LIS Technologies Receives Key Radioactive Material License from the State of Tennessee for its State-of-the-Art Test Demonstration Fa
-
Datacentrex Reports 48% Quarter-Over-Quarter Gross Profit Growth; Revenue Up 27%
-
Join Alliance Entertainment’s Exclusive Live Investor Webinar and Q&A Session on January 5
-
Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones
-
EMJX Expands Risk-Intelligence Framework with Prediction-Market Probability Data to Enhance Treasury Stress Detection
-
Versus Systems Executes Definitive Agreement with Drinkfinger to Power Global Beverage Engagement Network
-
Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial
-
DriveItAway Holdings Ignites National Scale with Free2move and Launches 9 New Cities in December
-
VisionWave Announces Issuance of New U.S. Patent, Expanding Enforceable Protection Across Its Core RF Imaging and AI Platform
-
AS Ekspress Grupp sells a shareholding in a Lithuanian company UAB Lrytas
-
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
-
Cipher Mining Announces Acquisition of 200 MW Site in Ohio
-
Diginex Provides Update on Acquisition Progress
-
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
-
VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio
-
SiriusPoint announces expansion of IMG services following acquisition of Assist America
-
Totaligent Wraps Up 2025 with Completion of Full Marketing Platform, Shares Holiday Message from CEO
-
MannKind Shares FUROSCIX® Business Updates
-
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Foresight Expands Road Safety Product Outreach in South Korea with a Strategic Cooperation Agreement
-
Net Asset Value(s)
-
Biometric Identification / Cybersecurity SaaS Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference Jan. 28 & 29 in Atlantic City, NJ
-
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
-
Willis Lease Finance Corporation Announces Closing of $392,900,000 in Fixed Rate Notes
-
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
-
Barnes & Noble Education Files “Super 10-K”, Reporting Full-Year Fiscal 2025 Financial Results, and Restated Financial Results for Prior Periods
-
Ronald P. Mathison and MATCO Investments Ltd. File Early Warning Report Regarding Calfrac Well Services Ltd.
-
Outpace Wins 144+ SEO Awards, Establishing Itself as one of the Best SEO Agencies in the US
-
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
-
New Research Shows Pressurized Oxygen Therapy’s Benefits Beyond Traditional Uses
-
Renewal Fuels (RNWF) & Its Subsidiary American Fusion Highlight Near-Term Commercial Fusion Strategy, Underscoring Key Distinctions Between Deployable Energy Infrastructure & Experimental Fusi
-
dLocal completes transition to a majority independent Board with appointments of Paco Ybarra and Nelson Mattos
